Data Integrity Crisis

A controversial study on hydroxychloroquine prompted the World Health Organization to pause a clinical trial, raising alarms about its data integrity. Investigators discovered inconsistencies and red flags surrounding the small, obscure company, Surgisphere, which claimed to have compiled extensive data from numerous hospitals. As scrutiny intensified, the lead researcher’s reluctance to provide raw data ultimately led to the retraction of the paper, highlighting serious concerns about research ethics in a time of crisis.